3409 results for «2023»

Filter By

3409 results

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques

Sensome announces data from two new studies showing clot-sensing guidewire successfully identifies fresh clot to support decision-making in peripheral artery disease treatment

13 Dec 2024

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

13 Nov 2024

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

EuroPCR 2022 – Together again!

25 May 2022

Paris, May 2022: A festive EuroPCR 2022 – the World Leading Course in interventional cardiovascular medicine – took place again in person, after a hiatus of 2 years caused by the COVID19 pandemic. The new blended EuroPCR format attracted 11,000 participants in person and online with...

EuroPCR 2022 – Together again!

MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study

25 Jan 2023

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) arterial disease

11 Feb 2023

BioCardia and StemCardia announce biotherapeutic delivery partnership

13 Mar 2024

Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart

14 Dec 2023

Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension

08 Nov 2023

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

13 Dec 2023

This case highlights the potential add-on value of reduced-order computational modeling over standard CT scan analysis due to its ability to predict the interaction of different devices or sizes with the patient-specific anatomy.

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

Simplified dual-indeflator approach for bioprosthetic valve fracture

02 Sep 2024

The standard BVF procedure involves multiple quick maneuvers. Simplifying the setup, minimizing operator actions, and shortening rapid pacing could reduce associated risks. Find out how!

Karim Ratib

Author

Karim Ratib
Dr. Andrija Matetic

Author

Andrija Matetic
Khaled Elsayed

Author

Khaled Elsayed
Simplified dual-indeflator approach for bioprosthetic valve fracture

GENESIS-II study reveals promising 30-day results for the hydra self-expanding transcatheter aortic valve

16 May 2024

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Lønborg

Author

Ali Nazmi Calik
NOTION 3

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease

02 Sep 2025

Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTION STEMI - Immediate vs staged complete revascularisation during index admission in patients with STEMI & MVD

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Trish Singh

Author

Trish Singh
PROCTOR: PCI of native coronary artery vs SVGin patients with prior CABG

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
Didn’t find what you were looking for?